BrainsWay Ltd. presented positive 12-month data on its accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) protocol for Major Depressive Disorder, showing over 80% remission rates and reduced functional impairment. The SWIFT protocol, cleared by the FDA in September 2025, significantly cuts down clinic visits. The company is experiencing strong financial performance with shares up 162% over the past year and reported a 29% revenue growth in the last twelve months, alongside a recent strategic investment in Hopemark Health.

Rockwell Automation has expanded its SecureOT solution suite with new offerings: the OT Cybersecurity Assessment Suite, SecureOT Platform Managed Services, and Managed Secure Remote Access (MSRA). These enhancements aim to help manufacturers operationalize cybersecurity, secure remote connectivity, and stay resilient against increasing cyber threats without needing additional infrastructure or specialized staff. The services leverage AI and machine learning to provide continuous, professionally managed risk prioritization and streamlined analysis.

Microchip Technology has released its TimePictra® 12 platform, a significant software upgrade for synchronization management designed to assist critical infrastructure operators in handling advanced timing architectures. This new version features a redesigned graphical user interface, expanded automation capabilities, and enhanced support for high-accuracy timing technologies. The platform aims to improve resilience, reduce GNSS dependence, and maintain precise clock alignment across various critical sectors like telecom, power, transportation, and data centers.

CECO Environmental (NASDAQ:CECO) has increased its full-year 2026 financial guidance after integrating Thermon Group Holdings, projecting a 20% rise in revenue to between $1.275 billion and $1.375 billion and a 25% increase in adjusted EBITDA to between $195 million and $225 million. The company aims for at least 55% of adjusted EBITDA to convert to free cash flow, with integration proceeding smoothly and early cost and commercial growth advantages being realized. CECO reaffirms its goal of achieving over $40 million in annualized cost synergies from the acquisition.

Audi has redesigned its Q7 and SQ7 models for 2027, featuring more powerful engines and new technology. The Q7 now comes with a 429-hp twin-turbo 2.9-liter V-6, while the SQ7's twin-turbo 4.0-liter V-8 sees a power increase to 591 hp. Both models will also offer Digital Matrix LED headlights in the U.S. for the first time and have updated interiors, with sales expected in the fourth quarter of this year.

This article lists 12 industrial stocks that are experiencing significant movement in Tuesday's pre-market session. It details both gainers and losers, providing their current stock prices, percentage changes, and market capitalization for companies like Smart Logistics Global, Elong Power Holding, Brenmiller Energy, CECO Environmental, Texxon Holding, and others. The movements range from a 137.4% increase for Smart Logistics Global to a 28.1% decrease for Texxon Holding.

Collins Aerospace, an RTX business, has significantly expanded its Maintenance, Repair, and Overhaul (MRO) facility in Subang, Malaysia, with a $63 million investment. This expansion quadruples its footprint, establishing the location as a key regional hub for advanced component MRO. The move aims to meet the growing demand in the Asia-Pacific region and is expected to double employment opportunities for skilled talent.

This article focuses on Boyd Gaming (BYD) and why it remains a relevant stock for U.S. investors, despite a lack of recent company-specific news. It highlights the company's exposure to regional gaming and digital wagering, its dependence on consumer spending and tourism, and the factors that typically influence its stock performance. The piece also discusses the risks associated with the casino industry and emphasizes that future earnings reports and operational updates will be key catalysts for investors.

Campbell’s Co. is confronting challenges in its Snacks business unit after a weak third-quarter performance in fiscal 2026, leading to plans for product portfolio rationalization, investment reallocations, and network consolidation. The salty snacks portfolio, including brands like Snyder’s of Hanover and Cape Cod, is particularly targeted for strengthening through sharpened price-pack architecture and improved trade efficiencies. Despite a decrease in quarterly sales and an 8% drop in US Soups sales, the company reaffirmed its fiscal 2026 guidance, while acknowledging potential elevated inflation in the first half of fiscal 2027 due to global conflicts.

Vertex Pharmaceuticals reported new clinical data for its cystic fibrosis therapy ALYFTREK in young children and detailed global regulatory submissions for ALYFTREK and TRIKAFTA for pediatric populations. These updates aim to broaden treatment access to children as young as 2 years old, with new Phase 3 data showing improved CFTR function, and extended safety findings in older patients. The company plans global submissions in the first half of 2026 for ALYFTREK and continues submissions for TRIKAFTA, reinforcing its leadership in the cystic fibrosis market while mitigating potential risks from competitors.